Novel Whole-Cell Inactivated <i>Neisseria Gonorrhoeae</i> Microparticles as Vaccine Formulation in Microneedle-Based Transdermal Immunization.

Gala, Rikhav P; Zaman, Rokon Uz; D'Souza, Martin J; Zughaier, Susu M

Novel Whole-Cell Inactivated Neisseria Gonorrhoeae Microparticles as Vaccine Formulation in Microneedle-Based Transdermal Immunization.

Gala, Rikhav P; Zaman, Rokon Uz; D'Souza, Martin J; Zughaier, Susu M.

Afiliación

Gala RP; Vaccine Nanotechnology Laboratory, Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA. rikhav.praful.gala@gmail.com.
Zaman RU; Vaccine Nanotechnology Laboratory, Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA. rokonuz.zaman@live.mercer.edu.
D'Souza MJ; Vaccine Nanotechnology Laboratory, Department of Pharmaceutical Sciences, College of Pharmacy, Mercer University, Atlanta, GA 30341, USA. DSOUZA_MJ@mercer.edu.
Zughaier SM; Department of Basic Medical Sciences, College of Medicine, Qatar University, Doha 2713, Qatar. szughaier@qu.edu.qa.

Vaccines (Basel) ; 6(3)2018 Sep 04.

Article en En | MEDLINE | ID: mdl-30181504

Palabras clave

Neisseria gonorrhoeae; antigen-specific CD4 T lymphocytes; antigen-specific antibody; gonorrhea; microneedle; nanotechnology; skin patch; vaccine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Vaccines (Basel) Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos